- Sandoz launches new ready to use oral formulation of ACC® in the Ukrainian market
- ACC® oral solution is used for children from 2 years old
- New form has cherry flavor and is available with convenient dispenser
Kiev, November 12, 2014 – Sandoz, the generic pharmaceutical division of Novartis, today announces the launch in Ukraine of a new ready-to-use oral formulation of ACC® cough medicine.
ACC® oral solution (active substance acetylcysteine) is used to treat acute and chronic bronchopulmonary diseases when it is necessary to reduce …